These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
8. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341 [TBL] [Abstract][Full Text] [Related]
9. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868 [TBL] [Abstract][Full Text] [Related]
10. Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy. Bakris G; White D J Hum Hypertens; 1997 Jan; 11(1):35-8. PubMed ID: 9111155 [TBL] [Abstract][Full Text] [Related]
12. Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy. Toto RD; Tian M; Fakouhi K; Champion A; Bacher P J Clin Hypertens (Greenwich); 2008 Oct; 10(10):761-9. PubMed ID: 19090877 [TBL] [Abstract][Full Text] [Related]
13. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM; Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578 [TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy. Guasch A; Parham M; Zayas CF; Campbell O; Nzerue C; Macon E J Am Soc Nephrol; 1997 May; 8(5):793-8. PubMed ID: 9176849 [TBL] [Abstract][Full Text] [Related]
15. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies. Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855 [TBL] [Abstract][Full Text] [Related]
16. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017 [TBL] [Abstract][Full Text] [Related]
17. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106 [TBL] [Abstract][Full Text] [Related]
18. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study. Rossing K; Christensen PK; Jensen BR; Parving HH Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908 [TBL] [Abstract][Full Text] [Related]
19. The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics. BENEDICT Group Control Clin Trials; 2003 Aug; 24(4):442-61. PubMed ID: 12865039 [TBL] [Abstract][Full Text] [Related]
20. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]